28 September 2022 Blog Post: Following the UK's Lead

Recent press reports have suggested that the UK could be heading into a fall COVID-19 wave with the United States not far behind (link: https://www.cnn.com/2022/09/27/health/uk-fall-wave-covid-us). It made me curious that this statement, and subsequent narrative, was accepted as a simple truism – with the first question being, is this in fact the case?

There is some precedent for this East to West movement. Influenza virus in the United States typically begins on the East Coast and moves to the West Coast. Here in Los Angeles, we tend to see a peak in flu cases in the last week of December, although there are certainly cases beforehand and afterwards.

The graph below shows case rates in the UK and the US.  There are clear overlaps corresponding to successive waves fueled by distinct variants.

With the first cases reported in March of 2020 in both countries, mitigation efforts kept cases rates low (relative as compared to the massive Omicron outbreak) until a clear January 2021 peak.  While there was not much genetic epidemiology being done at that time, the alpha variant was seen in March 2021 in 97% of UK cases and 15% of US cases. Although the UK had a more sharp peak than the US, it is clear that case rates in that instance accelerated before the UK.

The next clear rise in cases occurred in the summer of 2021 – fueled by the Delta variant.  In this instance the UK did take the lead with cases peaking the week of July 21st while the US topped out September 5th. Delta also began circulating first in the UK with 53.5% of cases in May being due to the variant as compared to 3.9% in the US.  By August 31st, 99.95% of cases in the UK and 99.44% of cases in the US were due to Delta.

The next big surge was Omicron, with the UK again taking the lead. Cases began to rise in the UK in late October and peaked the week of January 5th. The US had cases rising late November with a peak the week of January 14th. But this isn’t quite as simple (but still follows a pattern of the UK taking the lead) as one might think when considering the genetic epidemiology.  

In the UK in October, 99.97% of cases were Delta. In mid-December, over 60% of the cases were still Delta (40% Omicron, BA.1) and in early January 10% were Delta, 90% Omicron.  

In the US in October, 99.78% of cases were Delta. In mid-December, over 75% of the cases were still Delta (25% Omicron, BA.1) and in early January 16% were Delta, 84% Omicron.  

So what really occurred was a surge fueled by a mix of Delta and Omicron (BA.1) with the latter supplanting Delta as the primary circulating variant. Omicron took hold in the UK before the US, however.

The UK experienced a second Omicron wave in March of this year fueled by the BA.2 variant – something which simply did not occur in the US. In mid-March, 75% of cases in the US were still BA.1, 25% BA.2 as opposed to the UK where the opposite was seen: 20% of cases were BA.1 and 80% BA.2. Cases rose in the US in May, this time due to the BA.4 variant (accounting for 56% of cases and only 4% were BA.4) – a pattern which did not occur in the UK (80% of cases in the UK remained BA.2).

Dr. Tim Spector, professor of genetic epidemiology at Kings College London says, “Generally, what happens in the UK is reflected about a month later in the US.” Is this true?  Well sort of. It was not true for the Alpha variant, was most certainly true for Delta and again for Omicron. Interestingly, the distribution of BA.1, BA.2 and BA.4 has varied significantly during 2022 leading to a more short term trend where the US and UK are quite out of phase (Figure below).

Spector runs a study of about 500,000 individuals which uses an app to let people in the UK and US report their daily symptoms and record results of home antigen testing results. He states: “Our current data is definitely showing this is the beginning of the next wave,” Spector said.

Will the US follow suit? I think that largely depends on the behavior of BA.5 and which, if any, new variant takes hold. Currently the US and UK are aligned both in terms of case burden (US: 157 new daily cases per million, UK: 78) and variant proportion (US: 86% BA.5, UK: 89.4% BA.5).  

𝗦𝗶𝗴𝗻 𝗨𝗽 𝗳𝗼𝗿 𝗢𝘂𝗿 𝗡𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿

Dig deeper into the health topics you care about most by signing up for our newsletter.

by submitting this form you indicate you have
read and agree to our Privacy Policy and Terms
of Use. Please contact us to for us for more

Recommended Posts

No comment yet, add your voice below!

Add a Comment

Your email address will not be published. Required fields are marked *